Volkhard Lindner, MD, PhD

Faculty Scientist III

EDUCATION

MD, PhD: University of Tübingen
Postdoctoral Training: University of Washington, Seattle

Lindner Lab

Deciphering the functions of CTHRC1 in the regulation of metabolism and tissue repair.

Collagen Triple Helix Repeat Containing-1 (CTHRC1) Functions

The focus of our laboratory is on understanding the function of the gene Collagen Triple Helix Repeat Containing-1 (Cthrc1), which was discovered in our laboratory as a gene expressed in tissues undergoing remodeling.

Lindner Fig 1Figure 1. Cthrc1 is highly induced in the outer layer (adventitia) of arteries in response to injury. This layer undergoes a significant scarring process with abundant deposition of collagen, which leads to narrowing of the artery lumen.

Figure 2. CTHRC1 is not present in the normal heart (A), however, within 3 days following myocardial infarction CTHRC1 (in brown in B or green in C) is abundantly expressed in activated fibroblasts. Most of these myofibroblasts express both CTHRC1 and alpha-smooth muscle actin (in red in D).

Figure 3. CTHRC1 is expressed in bone by osteoblasts and osteocytes, not osteoclasts . (A) CTHRC1 is expressed in osteoblasts (arrowheads) and osteocytes of bone, whereas multinucleated osteoclasts (arrow) do not express CTHRC1. (B) Expression of the osteoclast marker TRAP (red) does not overlap with CTHRC1 (green) localization. (C-E) CTHRC1 is localized in cytoplasmic processes of osteocytes residing in the canaliculi. (F) Prominent accumulation of CTHRC1 is frequently seen around venules (arrows) suggesting potential release into circulation.

With genetic gain-of function and loss-of-function mouse models for Cthrc1 we seek to determine the functions of this molecule. Recent discoveries by our laboratory revealed that Cthrc1 functions as a predominantly bone-derived hormone (Figure 3) with substantial circulating levels detectable in some human subjects (Figure 6).

Evidence from genetic mouse models indicates that Cthrc1 plays a role in regulating body composition and voluntary physical activity. Increased body fat observed in Cthrc1 null mice is the result of inhibition of adipocyte differentiation by Cthrc1.

Lindner_Fig2

Figure 4. Cthrc1 null mice reveal increased visceral fat (in pink) and subcutaneous fat (in gray) as determined by microCT.

Figure 5. Inflammatory arthritis is exacerbated in Cthrc1 null mice. (A) In an inflammatory arthritis model CTHRC1 (brown) is expressed by the activated synoviocyte and in wildtype (WT) mice inflammation completely resolves without permanent joint damage (C). In Cthrc1 knockout mice no CTHRC1 is present in the inflamed joint (B) and massive inflammatory infiltrates persist with permanent damage to cartilage and bone (D).

Figure 6. The highest average plasma levels of CTHRC1 were observed in champion endurance athletes. Ironman: World Championship 2013; Ultramarathon: Trans-Europe Foot Race; HHH: Hotter’n Hell Hundred (100 mile cycling race).

Our laboratory is interested in determining the role of CTHRC1 induced during tissue repair such as after myocardial infarction. In addition, we seek to understand the significance of circulating CTHRC1 in athletic performance and inflammation.

References:

Pyagay P, Heroult M, Wang Q, Lehnert W, Belden J, Liaw L, Friesel RE, Lindner V. Collagen Triple Helix Repeat Containing 1 (Cthrc1), a novel secreted protein in injured and diseased arteries inhibits collagen expression and promotes cell migration. Circ.Res. 96: 281-268         (2005)

Stohn JP, Perreault NG, Wang Q, Liaw L, Lindner V. Cthrc1, a novel circulating    hormone regulating metabolism. PLoS One 2012;7(10):e47142.

Stohn JP, Wang Q, Siviski ME, Kennedy K, Jin Y-R, Kacer D, DeMambro V, Liaw L,       Vary CP, Rosen CJ, Prudovsky I, Lindner V. Cthrc1 Controls Adipose Tissue      Formation, Body Composition, and Physical Activity. Obesity 2015; 23:1633-1642.

Jin Y-R, Stohn JP, Wang Q, Nagano K, Baron R, Bouxsein ML, Rosen CJ, Adarichev VA, and Lindner V. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1. Bone 2017; 97:153-167.

Jin_Yongri_T

Yong-Ri Jin, PhD

Staff Scientist I
jiny@mmc.org

Mangoba_Armie_TArmie Mangoba

Technology Manager
mangog@mmc.org

Wang_Q_TQiaozeng Wang

Research Associate II
wangq@mmc.org

Left to Right: Yong-Ri Jin, Armie Mangoba, Qiaozeng Wang, Volkhard Lindner

A complete list of publications can be found on My NCBI

Jin Y-R, Stohn JP, Wang Q, Nagano K, Baron R, Bouxsein ML, Rosen CJ, Adarichev VA, and Lindner V. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1. Bone 2017; 97:153-167.

Stohn JP, Wang Q, Siviski ME, Kennedy K, Jin Y-R, Kacer D, DeMambro V, Liaw L, Vary CP, Rosen CJ, Prudovsky I, Lindner V. Cthrc1 Controls Adipose Tissue Formation, Body Composition, and Physical Activity. Obesity 2015; 23:1633-1642.

Duarte CW, Stohn JP, Wang Q, Emery IF, Prueser A, Lindner V. 2014. Elevated plasma levels of the pituitary hormone cthrc1 in individuals with red hair but not in patients with solid tumors. PLoS One 9: e100449.

Marks PC, Preda M, Henderson T, Liaw L, Lindner V, Friesel RE, Pinz IM. 2013. Interactive 3D analysis of blood vessel trees and collateral vessel volumes in magnetic resonance angiograms in the mouse ischemic hindlimb model. Open Med Imaging 7: 19-27.

Boucher JM, Harrington A, Rostama B, Lindner V, Liaw L. 2013. A receptor-specific function for Notch2 in mediating vascular smooth muscle cell growth arrest through p27kip1. Circ Res. 113: 975-985.

Liu G, Sengupta PK, Jamal B, Yang HY, Bouchie MP, Lindner V, Varelas X, Kukuruzinska MA. 2013. N-glycosylation induces the CTHRC1 protein and drives oral cancer cell migration. J Biol Chem. 288: 20217-20227.

Young K, Conley B, Romero D, Tweedie E, O’Neill C, Pinz I, Brogan L, Lindner V, Liaw L, Vary CP. 2012. BMP9 regulates endoglin-dependent chemokine responses in endothelial cells. Blood 120: 4263-4273.

Stohn JP, Perreault NG, Wang Q, Liaw L, Lindner V. 2012. Cthrc1, a novel circulating hormone regulating metabolism. PLoS One 7: e47142.

Apra C, Richard L, Coulpier F, Blugeon C, Gilardi-Hebenstreit P, Vallat JM, Lindner V, Charnay P, Decker L. 2012. Cthrc1 is a negative regulator of myelination in Schwann cells. Glia 60: 393-403.

Larman BW, Karolak MJ, Lindner V, Oxburgh L. 2012. Distinct bone morphogenetic proteins activate indistinguishable transcriptional responses in nephron epithelia including Notch target genes. Cell Signal 24: 257-264.

Cuttler AS, LeClair RJ, Stohn JP, Wang Q, Sorenson CM, Liaw L, Lindner V. 2011. Characterization of Pdgfrb-Cre transgenic mice reveals reduction of ROSA26 reporter activity in remodeling arteries. Genesis 49: 673-680.

McCulloch DR, Nelson CM, Dixon LJ, Silver DL, Wylie JD, Lindner V, Sasaki T, Cooley MA, Argraves WS, Apte SS. 2009. ADAMTS metalloproteases generate active versican fragments that regulate interdigital web regression. Dev Cell 17: 687-698.

Editorial Boards

  • Member, Editorial Board International Angiology

Teaching Responsibilities

  • Member of the Graduate Faculty, University of Maine, Orono, ME
  • Member Cell, Molecular and Developmental Biology Program, Tufts Sackler School of Graduate Biomedical Sciences